{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-274137","form_type":"8-K","ticker":"RVMD","cik":"0001628171","company_name":"Revolution Medicines, Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.836618+00:00","generated_at":"2026-06-08T06:47:26.624625+00:00","sec_items":["2.01","5.02","5.07","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Revolution Medicines completes acquisition of EQRx; exchange ratio 0.1112","bullets":["Acquisition closed Nov 9, 2023; EQRx stockholders received 0.1112 shares of RVMD common per EQRx share.","EQRx common stock and warrants delisted from Nasdaq; EQRx ceases as separate public company.","Sandra J. Horning appointed to RVMD board as EQRx designee, effective upon closing.","Share issuance proposal approved by ~90% of votes cast at special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-274137","json":"https://secwatch.observer/filing/0001193125-23-274137.json","markdown":"https://secwatch.observer/filing/0001193125-23-274137.md","text":"https://secwatch.observer/filing/0001193125-23-274137.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/0001193125-23-274137-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/d287738d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:47:26.624625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d07c06681b","claim":"Sandra J. Horning was appointed as Director at Revolution Medicines, Inc..","evidence_excerpt":"the Revolution Medicines board of directors (the “Board”) appointed Sandra J. Horning, M.D., as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/0001193125-23-274137-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d891766885c841ef437f454f1a62f81c6c95d022","claim":"Revolution Medicines, Inc. completed an acquisition involving EQRx, Inc. (closed 2023-11-09).","evidence_excerpt":"On November 9, 2023, Revolution Medicines, Inc., a Delaware corporation (“Revolution Medicines”), completed the previously announced acquisition of EQRx, Inc., a Delaware corporation (“EQRx”)","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/0001193125-23-274137-index.htm","confidence":0.98,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"EQRx, Inc."},{"label":"Closing","value":"2023-11-09"}],"fact_type":"ma_transaction"},{"claim_id":"f36f95b20923369c8ff00f3194756d1f09068f76","claim":"Revolution Medicines, Inc. shareholders approved Approval of the issuance of shares of Revolution Medicines Common Stock (including securities convertible into or exercisable for shares of Revolution Medicines Common Stock) to certain equityholders of EQRx pursuant to Merger Agreement (the \"Share Issuance Proposal\") at the 2023-11-08 meeting.","evidence_excerpt":"Proposal No. 1: Approval of the issuance of shares of Revolution Medicines Common Stock (including securities convertible into or exercisable for shares of Revolution Medicines Common Stock) to certain equityholders of EQRx pursuant to Merger Agreement (the “Share Issuance Proposal”). The Share Issuance Proposal was approved by the requisite vote of Revolution Medicines’ stockholders. Votes For Votes Against Abstentions Broker Non-Votes 85,738,003 9,442,157 123,934 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628171/000119312523274137/0001193125-23-274137-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-08"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}